Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Research who wrote (490)	2/11/1999 6:09:00 PM
From: Harold Beckwith	Read Replies (1) of 569

Why has Biomatrix pulled back 25%? The stock is acting just like it did before last earnings. I believe fear has returned to this stock as well as the shorts. Many are spinning that Cox-2 inhibitors will impact their sales. Not so, they are not any more effective than NSAID's in term of pain relief. There is a great opportunity in this stock. Earnings are expected to be .41 to .45 in Q4,'98. I believe just like before shorts will be surprised and the growth in this company is just beginning. HB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next